Chandrasekhar, Jaya
,
de Winter, Vera C.
Kalkman, Deborah N.
Sartori, Samantha
Chandiramani, Rishi
Aquino, Melissa B.
de Wilde, Puk
Zeebregts, Doreen
Woudstra, Pier
Beijk, Marcel A.
Hájek, Petr
Atzev, Borislav
Hudec, Martin
Ong, Tiong Kiam
Mates, Martin
Borisov, Borislav
Warda, Hazem M.
den Heijer, Peter
Wojcik, Jaroslaw
Iniguez, Andres
Coufal, Zdeněk
Lee, Michael
Tijssen, Jan G.
Koch, Karel T.
Baber, Usman
Dangas, George D.
Colombo, Antonio
de Winter, Robbert J.
Mehran, Roxana http://orcid.org/0000-0002-5546-262X
Funding for this research was provided by:
OrbusNeich Medical
Article History
Accepted: 22 September 2020
First Online: 30 January 2021
Compliance with Ethical Standards
:
: Dr. Mehran has received institutional research grant support from Eli Lilly/Daiichi-Sankyo Inc., AstraZeneca, The Medicines Company, Bristol-Myers Squibb, OrbusNeich, Beth Israel Deaconess, and Bayer; has served as a consultant for Boston Scientific, Cardiovascular Systems Inc., Medscape, and Shanghai BraccoSine Pharmaceutical; has received institutional advisory board funding from Bristol-Myers Squibb; has received institutional funding from Claret Medical; owns equity in Claret Medical and Elixir Medical; has served on the executive committee for Janssen Pharmaceuticals and Osprey Medical; has served on the data safety monitoring board for Watermark Research Partners; and has a spouse who has served as a consultant for Abiomed and the Medicines Company. All the other authors have no relevant disclosures.
: All participating sites obtained ethics approval or waiver to undertake the MASCOT or REMEDEE registry.
: All patients provided informed consent for inclusion in the study.
: Consent to analyze deidentified data and publish the results obtained.
: Not applicable.